Health News Archive - September 24, 2009
AMSTERDAM, September 24 /PRNewswire-FirstCall/ -- Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in human gene therapy, announced today the appointment of Jorn Aldag as its new Chief Executive Officer, starting October 5. Mr.
SEATTLE, Sept. 24 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc.
LEUVEN, Belgium, September 24 /PRNewswire-FirstCall/ -- - Enrolment of 326 Patients Completed Ahead of Schedule ThromboGenics NV (Euronext Brussels: THR), a biopharmaceutical company focused on the discovery and development of innovative treatments for eye disease, vascular disease and cancer, announces today that it has completed the enrolment of the US Phase III trial evaluating microplasmin for the non-surgical treatment of eye disease.
ANN ARBOR, Mich., Sept. 24 /PRNewswire/ -- Organizations representing the vast majority of cardiologists around the country have joined forces today to preserve and protect the highest quality cardiac care available in America.
ROCKVILLE, Md., Sept. 24 /PRNewswire/ -- A Phase III clinical trial involving more than 16,000 adult volunteers in Thailand has demonstrated that an investigational HIV vaccine regimen was safe and modestly effective in preventing HIV infection.
NEW YORK, Sept.
THOUSAND OAKS, Calif., Sept.
ROCHESTER, Minn. and REDMOND, Wash., Sept.
NEW YORK, Sept. 24 /PRNewswire/ -- An Ohio woman, 40-year-old Carolyn Savage, claims a fertility clinic implanted the wrong embryo and that the baby she's due to deliver the first week in October is not hers.
DALLAS, Sept. 24 /PRNewswire/ -- Dr. Dralves Edwards, a board-certified family physician in Dallas, today filed a civil case in the U.S.
- An uxorious, effeminate, or spiritless man.
- A timorous, cowardly fellow.